The Clinical Development team at Mersana Therapeutics plays a critical role in advancing the company’s antibody-drug conjugate therapies through clinical trials. This multidisciplinary group, comprising experts in clinical operations, research, biostatistics, and quality assurance, collaborates to design, implement, and oversee clinical studies that evaluate the safety and efficacy of new treatments for cancer patients. Their efforts ensure compliance with regulatory standards while facilitating the translation of innovative research into viable therapeutic options.
View all